Organised by Mexico, the International Drug Policy Consortium (IDPC), the Transnational Institute (TNI) and the Global Drug Policy Observatory (GDPO) Ambassador Alicia Buenrostro Massieu (Mexico). It is my pleasure to welcome you all today to this event on the margins of the thematic discussions of the Commission on Narcotic Drugs, dedicated to the implementation of the …
From Intersessional Meetings
CND Intersessional, 28 September 2017: Chapter 4 on human rights, women, youth and children
Post-UNGASS Facilitator. We will focus today on human rights, youth, children, women and communities. Valerie Lebaux, Chief, Justice Section, UNODC. Given the focus of this third round of intersessional discussions, technical assistance and international cooperation needs, I want to provide updates on UNODC’s technical assistance in supporting member states to implement chapter 4 of the …
CND Intersessional, 27 September 2017: Chapter 2 on access to controlled substances for medical and scientific purposes
Gilberto Gerra, UNODC. Only a few words from me to introduce my colleague. The rooms in the UN can be impermeable to sound, including the screaming of millions of people in unnecessary pain – people undergoing surgery, people suffering from pain. Thanks to cooperation with Belgium and others, we are working to overcome this – this …
CND Intersessional, 26 September 2017: Chapter 1 on demand reduction
CND Chair Ambassador Bente Angell-Hansen. I welcome participants to the CND intersessional. She reconfirmed that the extended bureau have confirmed the dates for the reconvened session of the 61st Session of the CND as the 6th – 7th December. Ahead of the reconvened there will be a report from UNODC Executive Director on gender balance & geographical …
CND Intersessional Meeting – 6 June 2017
CND Chair: Links to the presentations will be sent out to members. This is the first meeting after the productive sixtieth session. During that meeting, there were good resolutions and much scheduling, and the meeting ended on time. 1750 people were there and over one hundred side events occurred. The meeting functioned in an inclusive …
CND intersessional – 23 February 2017: Preparations for the 62nd Session in 2019
WHO: The role of the WHO is to determine whether drugs and NPS should be controlled or, if controlled, if their schedule should be changed. This decision is made by the ECDD with decisions made on scientific grounds. Elements considered include: likelihood of abuse (compared with existing controlled substances), convertibility into existing controlled substances, degree …